Page last updated: 2024-08-18

4-butyrolactone and Hemorrhagic Shock

4-butyrolactone has been researched along with Hemorrhagic Shock in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coppa, GF; Giangola, M; Jacob, A; Khader, A; Kuncewitch, M; Nicastro, J; Wang, P; Yang, WL	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Hemorrhagic Shock

Article	Year
Inhibition of fatty acid synthase with C75 decreases organ injury after hemorrhagic shock. Surgery, 2016, Volume: 159, Issue:2 Topics: 4-Butyrolactone; Animals; Biomarkers; Combined Modality Therapy; Crystalloid Solutions; Enzyme Inhibitors; Fatty Acid Synthases; Fluid Therapy; Isotonic Solutions; Lung Injury; Male; Rats; Rats, Sprague-Dawley; Rehydration Solutions; Resuscitation; Shock, Hemorrhagic; Treatment Outcome	2016

Article

Year

Inhibition of fatty acid synthase with C75 decreases organ injury after hemorrhagic shock.

Surgery, 2016, Volume: 159, Issue:2

Topics: 4-Butyrolactone; Animals; Biomarkers; Combined Modality Therapy; Crystalloid Solutions; Enzyme Inhibitors; Fatty Acid Synthases; Fluid Therapy; Isotonic Solutions; Lung Injury; Male; Rats; Rats, Sprague-Dawley; Rehydration Solutions; Resuscitation; Shock, Hemorrhagic; Treatment Outcome

2016